Are the New FDA Warning Letters Signaling Treatment of Hemp Extracts as Over the Counter Monographs? March 23, 2021 Justin Walsh Hemp Policy & Legal 1 Comment The FDA issued two new warning letters on March 22, 2021. Previous rounds of warning letters have focused on whether the companies have made statements that would make the product a drug. These have focused on such things as (1)… Read More→